Ignite Creation Date:
2025-12-24 @ 5:31 PM
Ignite Modification Date:
2026-01-29 @ 8:06 PM
Study NCT ID:
NCT00558168
Status:
COMPLETED
Last Update Posted:
2008-07-28
First Post:
2007-11-13
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Electronic Study for Anastrozole Pharmacovigilance Evaluation
Sponsor:
AstraZeneca
Organization:
Study Overview
Official Title:
Electronic Study for Anastrozole Pharmacovigilance Evaluation
Status:
COMPLETED
Status Verified Date:
2008-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
E-SAFE
Brief Summary:
Collecting information regarding adverse events from patients on treatment with anastrazole with early stage breast cancer
Detailed Description:
None
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: